Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Jan;45(1):139-45.

Genetic control of allogeneic interactions in the guinea-pig. IV. The specific elimination of MLC suppressor cells by the in vivo administration of antisera against a GPLA-B region-controlled determinant

Genetic control of allogeneic interactions in the guinea-pig. IV. The specific elimination of MLC suppressor cells by the in vivo administration of antisera against a GPLA-B region-controlled determinant

A F Geczy et al. Immunology. 1982 Jan.

Abstract

The in vivo effects of alloantisera, on the production of mixed leucocyte culture (MLC)-suppressor cells and suppressor factor (MLC-SF) as well as on the adoptive transfer of MLC suppression, were investigated. Intravenously administered anti-B.2 serum specifically eliminates B.2-associated MLC unresponsiveness and prevents the production of MLC-SF. By contrast, antisera directed against other B locus (homologous to the mouse H-2D or H-2K regions) or I region determinants do not appear to interfere with suppressor cell or factor production. Peritoneal exudate cells (PEC) from B.2-positive guinea-pigs can transfer MLC unresponsiveness to "normal' B.1-positive recipients; treatment of donor animals with anti-B.2 serum specifically prevents the transfer of MLC suppression. the results of this study support our earlier in vitro demonstration of B.2-bearing suppressor T cells which are sensitive to lysis by anti-B.2 sera in the presence of complement.

PubMed Disclaimer

Similar articles

References

    1. Transplantation. 1973 Aug;16(2):126-33 - PubMed
    1. J Immunol. 1975 May;114(5):1541-7 - PubMed
    1. J Immunol. 1975 Jul;115(1):204-10 - PubMed
    1. J Immunol. 1975 Dec;115(6):1704-10 - PubMed
    1. J Exp Med. 1976 Mar 1;143(3):672-7 - PubMed

Publication types

LinkOut - more resources